Breaking News

Immune Pharma Gains Exclusive License to Antibody Technology

December 29, 2015

Bispecific antibody demonstrated direct anti-cancer effects in vitro and in vivo

Immune Pharmaceuticals has entered into an exclusive license with Atlante Biotech SAS, for the patents and know-how for a new format of bispecific antibodies.
 
Recent data on the platform prototype bispecific antibody was shown to retain effector functions and mediate redirect killing of target cells by cytokine induced killer T cells. The bispecific antibody demonstrated direct anti-cancer effects in vitro, as well as in vivo anti-tumor activity and improved survival in a mouse xenograft model of disseminated leukemia.  
 
The R&D work on the bispecific antibodies will be performed in Immune's recently established Immunology R&D unit at the Alexandria Center for Life Sciences in New York, under Dr. Boris Shor, executive director of R&D, who joined the company from Pfizer Oncology.
 
Dr. Daniel Teper, chief executive officer of Immune said, "This is an important milestone as we make progress with our immuno-oncology pipeline. Our research will focus on the application of this novel bispecific platform to target immune checkpoints.  Our plan is to generate additional pre-clinical data with selected bispecific drug candidates in 2016."
blog comments powered by Disqus
  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • The Role of Alliances in Modern Drug Development

    The Role of Alliances in Modern Drug Development

    Dr. Claire Madden-Smith, Senior Vice President, Juniper Pharma Services||September 8, 2016
    Combining expertise to get drug candidates through development

  • Successful Method Transfer of Solid Oral Dosage

    Successful Method Transfer of Solid Oral Dosage

    John Frankonis, Ropack Pharma Solutions||June 2, 2016
    The three steps outlined will help guide the process of completing a successful analytical method transfer